Modugno F - Search Results

1

Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies.

Modugno F, Fu Z, Jordan SJ, Group A, Chang-Claude J, Fortner RT, Goodman MT, Moysich KB, Schildkraut JM, Berchuck A, Bandera EV, Qin B, Sutphen R, McLaughlin JR, Menon U, Ramus SJ, Gayther SA, Gentry-Maharaj A, Karpinskyj C, Pearce CL, Wu AH, Risch HA, Webb PM. Modugno F, et al. Eur J Epidemiol. 2020 Nov;35(11):1025-1042. doi: 10.1007/s10654-020-00682-9. Epub 2020 Sep 21. Eur J Epidemiol. 2020. PMID: 32959149 Free PMC article.

2

Cigarette smoking and the risk of mucinous and nonmucinous epithelial ovarian cancer.

Modugno F, Ness RB, Cottreau CM. Modugno F, et al. Epidemiology. 2002 Jul;13(4):467-71. doi: 10.1097/00001648-200207000-00016. Epidemiology. 2002. PMID: 12094103

3

Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.

Sit AS, Modugno F, Weissfeld JL, Berga SL, Ness RB. Sit AS, et al. Among authors: modugno f. Gynecol Oncol. 2002 Aug;86(2):118-23. doi: 10.1006/gyno.2002.6746. Gynecol Oncol. 2002. PMID: 12144815

4

Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States).

Modugno F, Moslehi R, Ness RB, Nelson DB, Belle S, Kant JA, Wheeler JE, Wonderlick A, Fishman D, Karlan B, Risch H, Cramer DW, Dube MP, Narod SA. Modugno F, et al. Cancer Causes Control. 2003 Jun;14(5):439-46. doi: 10.1023/a:1024932427503. Cancer Causes Control. 2003. PMID: 12946038

5

Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer.

Cottreau CM, Ness RB, Modugno F, Allen GO, Goodman MT. Cottreau CM, et al. Among authors: modugno f. Clin Cancer Res. 2003 Nov 1;9(14):5142-4. Clin Cancer Res. 2003. PMID: 14613992

6

Alcohol consumption and the risk of mucinous and nonmucinous epithelial ovarian cancer.

Modugno F, Ness RB, Allen GO. Modugno F, et al. Obstet Gynecol. 2003 Dec;102(6):1336-43. doi: 10.1016/j.obstetgynecol.2003.08.008. Obstet Gynecol. 2003. PMID: 14662224

7

Analysis of CHEK2 gene for ovarian cancer susceptibility.

Baysal BE, DeLoia JA, Willett-Brozick JE, Goodman MT, Brady MF, Modugno F, Lynch HT, Conley YP, Watson P, Gallion HH. Baysal BE, et al. Among authors: modugno f. Gynecol Oncol. 2004 Oct;95(1):62-9. doi: 10.1016/j.ygyno.2004.07.015. Gynecol Oncol. 2004. PMID: 15385111

8

Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.

Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT. Modugno F, et al. Am J Obstet Gynecol. 2004 Sep;191(3):733-40. doi: 10.1016/j.ajog.2004.03.035. Am J Obstet Gynecol. 2004. PMID: 15467532

9

Relations of gestational length and timing and type of incomplete pregnancy to ovarian cancer risk.

Gierach GL, Modugno F, Ness RB. Gierach GL, et al. Among authors: modugno f. Am J Epidemiol. 2005 Mar 1;161(5):452-61. doi: 10.1093/aje/kwi069. Am J Epidemiol. 2005. PMID: 15718481

10

Short-term oral contraceptive use and the risk of epithelial ovarian cancer.

Greer JB, Modugno F, Allen GO, Ness RB. Greer JB, et al. Among authors: modugno f. Am J Epidemiol. 2005 Jul 1;162(1):66-72. doi: 10.1093/aje/kwi162. Am J Epidemiol. 2005. PMID: 15961588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page